Which brings up back full circle to the value of WCL in its current form, there are a lot of coulda shoulda's in there. For an acquirer a fair price for control will not likely be >70c IMO.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution